Background illustration for clinical trials search

Paid Clinical Trials Dayton

Discover 1,171 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Cincinnati OH, Hilliard OH, Columbus OH,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female

Age: 18+

Code: NCT05128825

Phase2, Recruiting

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

for
Type 2 Diabetes, Cortisol Excess
Location: Cincinnati OH, Edgewood KY, Columbus OH, Troy MI,
Sponsor: Sparrow Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07296484

Phase2, Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

for
Alzheimer's Disease
Location: Blue Ash OH, Atlanta GA, Staten Island NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 55 - 70+

Code: NCT07011745

Phase3, Recruiting

An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome

for
Phelan-McDermid Syndrome
Location: Cincinnati OH, Chevy Chase MD, Lexington MA, Houston TX,
Sponsor: Neuren Pharmaceuticals Limited

Sex: All

Age: 3 - 12

Code: NCT07593391

Phase3, Recruiting

Impact of Integrated Care Pathways for Prevention of Post-operative Urinary Retention (POUR)

for
Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee,
Location: Cincinnati OH
Sponsor: TriHealth Inc.

Sex: All

Age: 18+

Code: NCT03863743

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Hydrus® Microstent New Enrollment Post-Approval Study

for
Primary Open Angle Glaucoma
Location: Cincinnati OH, Fraser MI, Kenosha WI, Chesterfield MO,
Sponsor: Alcon Research

Sex: All

Age: 45+

Code: NCT04553523

Recruiting

Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects

for
Full Aniridia, Partial Aniridia
Location: Cincinnati OH, Philadelphia PA, Los Angeles CA
Sponsor: Clinical Research Consultants, Inc.

Sex: All

Age: 3+

Code: NCT01860612

Recruiting

Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

for
Stargardt Disease, Cone Rod Dystrophy,
Location: Cincinnati OH, Ann Arbor MI, Baltimore MD, Boston MA,
Sponsor: Ascidian Therapeutics, Inc

Sex: All

Age: 12+

Code: NCT06467344

Phase1, Phase2, Recruiting

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

for
Geographic Atrophy, Macular Degeneration
Location: Cincinnati OH, Carmel IN, Cleveland OH, Grand Rapids MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 60+

Code: NCT06635148

Phase2, Recruiting

Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial

for
Proliferative Vitreoretinopathy,
Location: Cincinnati OH
Sponsor: Cincinnati Eye Institute, Southwest Ohio

Sex: All

Age: 18+

Code: NCT06541574

Phase2, Recruiting

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

for
Macular Telangiectasia Type 2 (MacTel)
Location: Cincinnati OH, Cleveland OH, Grand Rapids MI,
Sponsor: Neurotech Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06971939

Recruiting

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Cincinnati OH, Ann Arbor MI, Pittsburgh PA, Chicago IL,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 6+

Code: NCT07425574

Recruiting

Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)

for
ARB, BVMD, Autosomal-Dominant Bestrophinopathy,
Location: Cincinnati OH, Dallas TX, Los Angeles CA
Sponsor: Opus Genetics, Inc

Sex: All

Age: 18+

Code: NCT07185256

Phase1, Phase2, Recruiting

ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty

for
Corneal Transplant Failure
Location: Cincinnati OH, Indianapolis IN, Ann Arbor MI, Durham NC,
Sponsor: Massachusetts Eye and Ear Infirmary

Sex: All

Age: 18+

Code: NCT06753916

Phase2, Recruiting

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

for
Neovascular Age-Related Macular Degeneration (nAMD)
Location: Cincinnati OH, Carmel IN, Oak Forest IL,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 50+

Code: NCT07064759

Phase3, Recruiting

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

for
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Location: Cincinnati OH, Dublin OH, Columbus OH, Louisville KY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT06541704

Phase3, Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

for
Advanced Cancer, Metastatic Cancer, Ovarian Cancer,
Location: Cincinnati OH, Indianapolis IN, Maumee OH, Hinsdale IL,
Sponsor: Artios Pharma Ltd

Sex: All

Age: 18+

Code: NCT04657068

Phase1, Phase2, Recruiting

Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)

for
Carotid Artery Calcification, Carotid Artery Diseases
Location: Cincinnati OH, Park Ridge IL, Saginaw MI, Bay City MI,
Sponsor: Shockwave Medical, Inc.

Sex: All

Age: 18+

Code: NCT07062471

Recruiting

Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

for
Glaucoma
Location: Cincinnati OH
Sponsor: Glaukos Corporation

Sex: All

Age: 35+

Code: NCT06057051

Recruiting

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

for
Heart Failure, Heart Failure With Reduced Ejection Fraction
Location: Richmond IN, Cincinnati OH, Cleveland OH, Detroit MI,
Sponsor: Cytokinetics

Sex: All

Age: 18 - 70+

Code: NCT06736574

Phase3, Recruiting